694 related articles for article (PubMed ID: 16513211)
1. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
2. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
4. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
5. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
6. Functional CRF receptors in BON cells stimulate serotonin release.
von Mentzer B; Murata Y; Ahlstedt I; Lindström E; Martínez V
Biochem Pharmacol; 2007 Mar; 73(6):805-13. PubMed ID: 17184738
[TBL] [Abstract][Full Text] [Related]
7. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
8. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
Staub DR; Evans AK; Lowry CA
Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
[TBL] [Abstract][Full Text] [Related]
9. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
10. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
[TBL] [Abstract][Full Text] [Related]
11. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
13. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
Bagosi Z; Jászberényi M; Szabó G; Telegdy G
Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
15. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
[TBL] [Abstract][Full Text] [Related]
16. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
17. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.
Jahn O; Tezval H; van Werven L; Eckart K; Spiess J
Neuropharmacology; 2004 Aug; 47(2):233-42. PubMed ID: 15223302
[TBL] [Abstract][Full Text] [Related]
18. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
20. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]